Machine Learning Prediction of Respiratory Muscle Changes and Ventilatory Responses After Incretin-Based Therapy in Obesity

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age25-60
SponsorBiruni University

About this trial

This study aims to evaluate changes in respiratory function, respiratory muscle performance, and ventilatory responses following incretin-based therapy in individuals with obesity, and to identify predictors of these changes through the application of machine learning methods.

Eligibility criteria

Qualifiers

Individuals aged 25-60 years

Individuals with a body mass index (BMI) ≥ 30 kg/m² according to the World - Health Organization (WHO) classification of obesity

Individuals who voluntarily agree to participate in the study

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Incretin-based therapy

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators